Terramed Alliance News Younger ****** Cancer Patients Have Greater Chance Of Recurrence, Especially After Certain Treatments
Posted by in 1042 on 10-12-2009
Terramed Alliance ****** Cancer Org. asked:
Previous studies have shown that younger ****** cancer patients consistently have poorer outcomes than patients who develop the disease later in life, which can translate into lower rates of overall survival. While the reason for this is not known, it is suggested that ****** cancer in younger patients is more biologically aggressive.
Researchers from the University of Texas M.D. Anderson Cancer Center in Houston sought to determine which form of ****** cancer treatment – breast-conserving therapy, mastectomy alone or mastectomy with adjuvant radiation – better benefits younger women with either Stage I or Stage II ****** cancer.
A total of 652 young women with ****** cancer from 1973 to 2006 were studied, with 197 of the patients having received breast-conserving therapy, 237 having received a mastectomy and 234 having received mastectomy with adjuvant radiation. The study authors confirmed that younger ****** cancer patients do have relatively high locoregional recurrence rates, but that patients with Stage II disease achieved the best locoregional control rates with mastectomy plus adjuvant radiation therapy. Patients with Stage I disease had similar outcomes with breast-conserving therapy and mastectomy, but adding chemotherapy to either treatment was beneficial.
“Locoregional recurrence after optimal ****** cancer treatment in young women remains a significant problem,” Beth Beadle, M.D., Ph.D., a resident at M. D. Anderson and lead author of the study, said. “Our study hopefully will help radiation oncologists plan therapies for younger ****** cancer patients, who have inferior outcomes compared to older patients, and generate new interest in prospective studies to evaluate the best treatment strategies for these young women.” American Society for Therapeutic Radiology and Oncology (2009). Younger ****** Cancer Patients Have Greater Chance Of Recurrence, Especially After Certain Treatments. ScienceDaily.
Terramed Alliance is a non-profit charity organization dedicated to research, education and advocacy of ****** cancer. One of the vision of Terramed Alliance is to provide this community and Internet users with a charity based research and education entity. Advocacy of ****** cancer through education is vital to the reduction of this disease. For any requests and enquiries, please contact at us: cancer@terramedalliance.us www.terramedalliance.us
Previous studies have shown that younger ****** cancer patients consistently have poorer outcomes than patients who develop the disease later in life, which can translate into lower rates of overall survival. While the reason for this is not known, it is suggested that ****** cancer in younger patients is more biologically aggressive.
Researchers from the University of Texas M.D. Anderson Cancer Center in Houston sought to determine which form of ****** cancer treatment – breast-conserving therapy, mastectomy alone or mastectomy with adjuvant radiation – better benefits younger women with either Stage I or Stage II ****** cancer.
A total of 652 young women with ****** cancer from 1973 to 2006 were studied, with 197 of the patients having received breast-conserving therapy, 237 having received a mastectomy and 234 having received mastectomy with adjuvant radiation. The study authors confirmed that younger ****** cancer patients do have relatively high locoregional recurrence rates, but that patients with Stage II disease achieved the best locoregional control rates with mastectomy plus adjuvant radiation therapy. Patients with Stage I disease had similar outcomes with breast-conserving therapy and mastectomy, but adding chemotherapy to either treatment was beneficial.
“Locoregional recurrence after optimal ****** cancer treatment in young women remains a significant problem,” Beth Beadle, M.D., Ph.D., a resident at M. D. Anderson and lead author of the study, said. “Our study hopefully will help radiation oncologists plan therapies for younger ****** cancer patients, who have inferior outcomes compared to older patients, and generate new interest in prospective studies to evaluate the best treatment strategies for these young women.” American Society for Therapeutic Radiology and Oncology (2009). Younger ****** Cancer Patients Have Greater Chance Of Recurrence, Especially After Certain Treatments. ScienceDaily.
Terramed Alliance is a non-profit charity organization dedicated to research, education and advocacy of ****** cancer. One of the vision of Terramed Alliance is to provide this community and Internet users with a charity based research and education entity. Advocacy of ****** cancer through education is vital to the reduction of this disease. For any requests and enquiries, please contact at us: cancer@terramedalliance.us www.terramedalliance.us
